BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37702275)

  • 1. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
    Kuo HC
    Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
    Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
    Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
    Jhang JF; Lin TY; Kuo HC
    Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection.
    Jhang JF; Jiang YH; Hsu YH; Ho HC; Birder LA; Lin TY; Kuo HC
    Int Neurourol J; 2022 Feb; 26(Suppl 1):S57-67. PubMed ID: 35073671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma.
    Lee YK; Jiang YH; Jhang JF; Ho HC; Kuo HC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.
    Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
    Jhang JF; Wu SY; Lin TY; Kuo HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis.
    Jiang YH; Kuo YC; Jhang JF; Lee CL; Hsu YH; Ho HC; Kuo HC
    Sci Rep; 2020 Sep; 10(1):15218. PubMed ID: 32939046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
    Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved symptoms and signs of refractory interstitial cystitis in women after intravesical Nanofat plus platelet-rich plasma grafting: A pilot study.
    Hung MJ; Tsai CP; Ying TH; Chen GD; Su HL; Tseng CJ
    J Chin Med Assoc; 2022 Jun; 85(6):730-735. PubMed ID: 35507021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early three-month report of amniotic bladder therapy in patients with interstitial cystitis/bladder pain syndrome.
    Madan R; Radoiu C; Liaw A; Lucas S; Hamada A; Dhar N
    Int Urol Nephrol; 2023 Aug; 55(8):1937-1942. PubMed ID: 37273012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome-A Comparative Study of Different Injection Number, Additives and Concentrations.
    Jiang YH; Jhang JF; Lin TY; Ho HC; Hsu YH; Kuo HC
    Front Pharmacol; 2022; 13():853776. PubMed ID: 35392571
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jiang YH; Jhang JF; Chang WC; Kuo HC
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
    Lee CL; Jiang YH; Kuo HC
    BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis.
    Wyndaele JJJ; Riedl C; Taneja R; Lovász S; Ueda T; Cervigni M
    Neurourol Urodyn; 2019 Feb; 38(2):535-544. PubMed ID: 30592544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection.
    Jhang JF; Jiang YH; Lin TY; Kuo HC
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis.
    Chen JL; Kuo HC
    Investig Clin Urol; 2020 Feb; 61(Suppl 1):S33-S42. PubMed ID: 32055752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.